Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2011

01-12-2011 | Epidemiology

Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis

Authors: S. Warren Andersen, P. A. Newcomb, J. M. Hampton, L. Titus-Ernstoff, K. M. Egan, A. Trentham-Dietz

Published in: Breast Cancer Research and Treatment | Issue 3/2011

Login to get access

Abstract

Evidence suggests that certain reproductive factors are more strongly associated with the incidence of lobular than of ductal breast cancer. The mechanisms influencing breast cancer incidence histology may also affect survival. Women with invasive breast cancer (N = 22,302) diagnosed during 1986–2005 were enrolled in a series of population-based studies in three US states. Participants completed telephone interviews regarding reproductive exposures and other breast cancer risk factors. Histologic subtype was obtained from state cancer registries. Vital status and cause of death were determined through December 2006 using the National Death Index. Women were followed for 9.8 years on average with 3,050 breast cancer deaths documented. Adjusted hazard rate ratios (HR) and 95% confidence intervals (95% CI) were calculated using Cox proportional hazards regression models for breast cancer-specific and all-cause mortality. Parity was inversely associated with breast cancer-specific mortality (P Trend = 0.002). Associations were similar though attenuated for all-cause mortality. In women diagnosed with ductal breast cancer, a 15% reduction in breast cancer-specific mortality was observed in women with five or more children when compared to those with no children (HR = 0.85, 95% CI: 0.73–1.00). A similar inverse though non-significant association was observed in women with lobular subtype (HR = 0.70, 95% CI: 0.43–1.14). The trend did not extend to mixed ductal–lobular breast cancer. Age at first birth had no consistent relationship with breast cancer-specific or all-cause mortality. We found increasing parity reduced mortality in ductal and lobular breast cancer. The number of full-term births, rather than age at first birth, has an effect on both breast cancer-specific and overall mortality.
Literature
1.
go back to reference Newcomb PA, Trentham-Dietz A, Hampton JM, Egan KM, Titus-Ernstoff L, Warren Andersen S, Greenberg ER, Willett WC (2011) Late age at first full term birth is strongly associated with lobular breast cancer. Cancer 117(9):1946–1956 Newcomb PA, Trentham-Dietz A, Hampton JM, Egan KM, Titus-Ernstoff L, Warren Andersen S, Greenberg ER, Willett WC (2011) Late age at first full term birth is strongly associated with lobular breast cancer. Cancer 117(9):1946–1956
2.
go back to reference Rosenberg L, Thalib L, Adami HO, Hall P (2004) Childbirth and breast cancer prognosis. Int J Cancer 111(5):772–776PubMedCrossRef Rosenberg L, Thalib L, Adami HO, Hall P (2004) Childbirth and breast cancer prognosis. Int J Cancer 111(5):772–776PubMedCrossRef
3.
go back to reference Olson SH, Zauber AG, Tang J, Harlap S (1998) Relation of time since last birth and parity to survival of young women with breast cancer. Epidemiology 9(6):669–671PubMedCrossRef Olson SH, Zauber AG, Tang J, Harlap S (1998) Relation of time since last birth and parity to survival of young women with breast cancer. Epidemiology 9(6):669–671PubMedCrossRef
4.
go back to reference Anderson PR, Hanlon AL, Freedman GM, Nicolaou N (2004) Parity confers better prognosis in older women with early-stage breast cancer treated with breast-conserving therapy. Clin Breast Cancer 5(3):225–231PubMedCrossRef Anderson PR, Hanlon AL, Freedman GM, Nicolaou N (2004) Parity confers better prognosis in older women with early-stage breast cancer treated with breast-conserving therapy. Clin Breast Cancer 5(3):225–231PubMedCrossRef
5.
go back to reference Schouten LJ, Hupperets PS, Jager JJ, Volovics L, Wils JA, Verbeek AL, Blijham GH (1997) Prognostic significance of etiological risk factors in early breast cancer. Breast Cancer Res Treat 43(3):217–223PubMedCrossRef Schouten LJ, Hupperets PS, Jager JJ, Volovics L, Wils JA, Verbeek AL, Blijham GH (1997) Prognostic significance of etiological risk factors in early breast cancer. Breast Cancer Res Treat 43(3):217–223PubMedCrossRef
6.
go back to reference Reeves GK, Patterson J, Vessey MP, Yeates D, Jones L (2000) Hormonal and other factors in relation to survival among breast cancer patients. Int J Cancer 89(3):293–299PubMedCrossRef Reeves GK, Patterson J, Vessey MP, Yeates D, Jones L (2000) Hormonal and other factors in relation to survival among breast cancer patients. Int J Cancer 89(3):293–299PubMedCrossRef
7.
go back to reference Barnett GC, Shah M, Redman K, Easton DF, Ponder BA, Pharoah PD (2008) Risk factors for the incidence of breast cancer: do they affect survival from the disease? J Clin Oncol 26(20):3310–3316PubMedCrossRef Barnett GC, Shah M, Redman K, Easton DF, Ponder BA, Pharoah PD (2008) Risk factors for the incidence of breast cancer: do they affect survival from the disease? J Clin Oncol 26(20):3310–3316PubMedCrossRef
8.
go back to reference Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA (2004) Reproductive history and mortality after breast cancer diagnosis. Obstet Gynecol 104(1):146–154PubMedCrossRef Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA (2004) Reproductive history and mortality after breast cancer diagnosis. Obstet Gynecol 104(1):146–154PubMedCrossRef
9.
go back to reference Kroman N, Wohlfahrt J, Andersen KW, Mouridsen HT, Westergaard T, Melbye M (1998) Parity, age at first childbirth and the prognosis of primary breast cancer. Br J Cancer 78(11):1529–1533PubMedCrossRef Kroman N, Wohlfahrt J, Andersen KW, Mouridsen HT, Westergaard T, Melbye M (1998) Parity, age at first childbirth and the prognosis of primary breast cancer. Br J Cancer 78(11):1529–1533PubMedCrossRef
10.
go back to reference Lees AW, Jenkins HJ, May CL, Cherian G, Lam EW, Hanson J (1989) Risk factors and 10-year breast cancer survival in northern Alberta. Breast Cancer Res Treat 13(2):143–151PubMedCrossRef Lees AW, Jenkins HJ, May CL, Cherian G, Lam EW, Hanson J (1989) Risk factors and 10-year breast cancer survival in northern Alberta. Breast Cancer Res Treat 13(2):143–151PubMedCrossRef
11.
go back to reference Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Kaufman JS, Moorman PG, Cai J, Olshan AF, Porter PL, Brinton LA, Eley JW, Coates RJ (2007) Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat 103(1):93–102PubMedCrossRef Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Kaufman JS, Moorman PG, Cai J, Olshan AF, Porter PL, Brinton LA, Eley JW, Coates RJ (2007) Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat 103(1):93–102PubMedCrossRef
12.
go back to reference Greenberg ER, Vessey MP, McPherson K, Doll R, Yeates D (1985) Body size and survival in premenopausal breast cancer. Br J Cancer 51(5):691–697PubMedCrossRef Greenberg ER, Vessey MP, McPherson K, Doll R, Yeates D (1985) Body size and survival in premenopausal breast cancer. Br J Cancer 51(5):691–697PubMedCrossRef
13.
go back to reference Newcomer LM, Newcomb PA, Potter JD, Yasui Y, Trentham-Dietz A, Storer BE, Longnecker MP, Baron JA, Daling JR (2003) Postmenopausal hormone therapy and risk of breast cancer by histologic type (US). Cancer Causes Control 14(3):225–233PubMedCrossRef Newcomer LM, Newcomb PA, Potter JD, Yasui Y, Trentham-Dietz A, Storer BE, Longnecker MP, Baron JA, Daling JR (2003) Postmenopausal hormone therapy and risk of breast cancer by histologic type (US). Cancer Causes Control 14(3):225–233PubMedCrossRef
14.
go back to reference Sprague BL, Trentham-Dietz A, Newcomb PA, Titus-Ernstoff L, Hampton JM, Egan KM (2007) Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev 16(2):236–243PubMedCrossRef Sprague BL, Trentham-Dietz A, Newcomb PA, Titus-Ernstoff L, Hampton JM, Egan KM (2007) Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev 16(2):236–243PubMedCrossRef
15.
go back to reference World Health Organization (1976) International Classification of Diseases for Oncology: ICD-O. 1st edn. World Health Organization, Geneva World Health Organization (1976) International Classification of Diseases for Oncology: ICD-O. 1st edn. World Health Organization, Geneva
16.
go back to reference World Health Organization (1990) International Classification of Diseases for Oncology: ICD-O, 2nd edn. World Health Organization, Geneva World Health Organization (1990) International Classification of Diseases for Oncology: ICD-O, 2nd edn. World Health Organization, Geneva
17.
go back to reference World Health Organization (2000) International Classification of Diseases for Oncology: ICD-O, 3rd edn. World Health Organization, Geneva World Health Organization (2000) International Classification of Diseases for Oncology: ICD-O, 3rd edn. World Health Organization, Geneva
19.
go back to reference World Health Organization (1978) International Classification of Diseases, Ninth Revision. 9th edn. World Health Organization, Geneva World Health Organization (1978) International Classification of Diseases, Ninth Revision. 9th edn. World Health Organization, Geneva
20.
go back to reference Papatestas AE, Mulvihill M, Josi C, Ioannovich J, Lesnick G, Aufses AH Jr (1980) Parity and prognosis in breast cancer. Cancer 45(1):191–194PubMedCrossRef Papatestas AE, Mulvihill M, Josi C, Ioannovich J, Lesnick G, Aufses AH Jr (1980) Parity and prognosis in breast cancer. Cancer 45(1):191–194PubMedCrossRef
21.
go back to reference Balogh GA, Heulings R, Mailo DA, Russo PA, Sheriff F, Russo IH, Moral R, Russo J (2006) Genomic signature induced by pregnancy in the human breast. Int J Oncol 28(2):399–410PubMed Balogh GA, Heulings R, Mailo DA, Russo PA, Sheriff F, Russo IH, Moral R, Russo J (2006) Genomic signature induced by pregnancy in the human breast. Int J Oncol 28(2):399–410PubMed
22.
go back to reference Lea CS, Gordon NP, Prebil LA, Ereman R, Uratsu CS, Powell M (2009) Differences in reproductive risk factors for breast cancer in middle-aged women in Marin County, California and a sociodemographically similar area of Northern California. BMC Womens Health 9:6PubMedCrossRef Lea CS, Gordon NP, Prebil LA, Ereman R, Uratsu CS, Powell M (2009) Differences in reproductive risk factors for breast cancer in middle-aged women in Marin County, California and a sociodemographically similar area of Northern California. BMC Womens Health 9:6PubMedCrossRef
23.
go back to reference Fillenbaum GG, Burchett BM, Blazer DG (2009) Identifying a national death index match. Am J Epidemiol 170(4):515–518PubMedCrossRef Fillenbaum GG, Burchett BM, Blazer DG (2009) Identifying a national death index match. Am J Epidemiol 170(4):515–518PubMedCrossRef
24.
go back to reference Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE (2009) Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol 169(10):1251–1259PubMedCrossRef Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE (2009) Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol 169(10):1251–1259PubMedCrossRef
25.
go back to reference Li CI, Uribe DJ, Daling JR (2005) Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93(9):1046–1052PubMedCrossRef Li CI, Uribe DJ, Daling JR (2005) Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93(9):1046–1052PubMedCrossRef
Metadata
Title
Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis
Authors
S. Warren Andersen
P. A. Newcomb
J. M. Hampton
L. Titus-Ernstoff
K. M. Egan
A. Trentham-Dietz
Publication date
01-12-2011
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2011
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-011-1666-0

Other articles of this Issue 3/2011

Breast Cancer Research and Treatment 3/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine